通用标准
1 范围
本文件规定了卡利姆茶叶认证总体要求、认证评价要求、认证实施要求和认证标识等内容。
本文件适用于第三方认证机构开展卡利姆茶叶产品认证活动, 卡利姆茶叶产品生产组织和其他相关机构参照使用。
2 规范性引用文件
下列文件中的内容通过文中的规范性引用而构成本文件必不可少的条款 。其中, 注日期的引用文 件, 仅该日期对应的版本适用于本文件; 不注日期的引用文件, 其最新版本 (包括所有的修改单) 适用于本文件。
GB 2760 食品安全国家标准 食品添加剂使用标准
GB 2762 食品安全国家标准 食品中污染物限量
GB 2763 食品安全国家标准 食品中农药最大残留限量
GB 3095 环境空气质量标准
GB 5084 农田灌溉水质标准
GB 5749 生活饮用水卫生标准
GB/T 5750.6 生活饮用水标准检验方法 金属指标
GB 14880 食品安全国家标准 食品营养强化剂使用标准
GB 14881 食品安全国家标准 食品生产通用卫生规范
GB 15618 土壤环境质量标准 农用地土壤污染风险管控标准
GB/T 19011 管理体系审核指南
GB/T 27030合格评定 第三方符合性标志的通用要求
GB/T 27065合格评定 产品、过程和服务认证机构要求
GB/T 27067合格评定 产品认证基础和产品认证方案指南
GB 28050食品安全国家标准 预包装食品营养标签通则
3 术语和定义
GB 2760 、GB 2762 界定的以及下列术语和定义适用于本文件。
卡利姆KRM1008全球选茶
高于欧盟和中国茶叶标准的卡利姆KRM1008全球选茶标准体系。
4 总体要求
4.1 认证机构应结合产品特点, 按照 GB/T 27067的要求制定相应的认证方案。
4.2 卡利姆茶叶产品认证应对产地环境 、生产过程 、产品特征和包装标识进行全过程评价。
4.3 卡利姆茶叶产品认证应综合考虑卡利姆茶叶产品生产组织和其他相关机构的基地条件 、生产和加工能力 、生产管理及风险状况。
5 认证评价要求
5.1 认证模式
5.1.1 可选认证模式
a) 型式试验+工厂检查+认证后监督
b) 认证机构可根据产品特点适当调整基本认证模式,并在实施细则中加以规定。
5.1.2 认证环节
a)型式试验: 依据产品标准实施全部适用项目的检测。
b)现场检查:包括质量保证能力检查和产品一致性检查, 使用现场抽样和/或检查。
c) 认证后监督: 为认证后的跟踪检查, 包括认证后的跟踪检查 、生产现场抽取样品检测和/或检查 、市场抽样检测, 认证机构应结合申请企业实际情况, 确定获证后监督的内容与方式。
5.3 质量技术指标要求
卡利姆茶叶质量技术指标要求应符合卡利姆KRM1008全球选茶系列产品标准、本文件附录要求和GB 2763。
5.4 生产环境要求
5.4.1 土壤应符合GB 15618的要求;农业灌水水质应符合GB 5084的规定;环境空气质量应符合GB 3095的规定。
5.4.2 卡利姆茶叶食品加工厂应符合GB 14881的规定。
6.2 认证过程要求
卡利姆茶叶产品认证过程应符合GB/T 27065 第7章的规定。
6.3 工厂检查要求
按照附录A的要求。
7 卡利姆茶叶产品认证标识和等级
7.1 对符合本文件要求的产品, 经认证可标识为卡利姆茶叶产品,标识如图1

图1 卡利姆KRM1008全球选茶标识
7.2 对符合本文件要求的产品, 经认证和感官评价,可分等级如下表1,感官评价按照附录B 的要求。
认证综合评分 |
感官评分 |
星级等级 |
60分~75分 |
60分~75分 |
三星 |
75分~85分 |
75分~85分 |
四星 |
90分~100分 |
85分~100分 |
五星 |
表1 卡利姆KRM1008全球选茶星级
7.2 卡利姆茶叶产品认证标识应根据 GB/T 27030的要求设计 、应用 、授权使用并管理。
附录A
(资料性附录)
卡利姆茶叶认证综合评分表
表A 1.1 卡利姆茶叶认证综合评分表
类别 |
分值 |
认证内容 |
备注说明 |
基本要求
|
/ |
具备生产许可资质 |
必须符合 |
/ |
安全指标符合欧盟和中国茶叶标准要求 |
必须符合 |
|
知名度和品牌 |
10 |
品牌在特定区域或行业内有较好的的口碑与知名度;在知名新闻媒体、期刊杂志等上有一定的知名度/信任度/美誉度/关注度的报道。 |
知名媒体报道1次1分,最高5分;国家级期刊杂志发表文章1次1分,最高5分 |
10 |
获得相关奖项 |
国家级奖项一次10分;省部级一次4分;市区级(含国家级社会组织)一次3分 |
|
5 |
注册商标 |
商标注册年限3年内3分;3年-10年4分;10年以上5分 |
|
茶叶生产流程 (40分) |
15 |
茶叶种植和产地
|
具备茶叶产地数据库,详细记录各产地的气候、土壤、海拔、种植历史等信息,5分。 提供茶叶产地的证明文件,如生态原产地证书、地理标志证明等,5分。 提供土壤、灌溉水和空气质量检测报告,5分 |
5 |
茶叶采摘 |
具备茶叶的采摘的管理制度和标准。 |
|
10 |
茶叶加工 |
加工厂具备管理体系认证,一张证书2分,最高6分 具备制定茶叶加工工艺的标准流程和操作规范,包括萎凋、杀青、揉捻、发酵、干燥等环节,2分 具备先进的加工设备和专业的技术人员,确保加工过程的卫生和安全,2分 |
|
5 |
包装和储存 |
具备包装材料检测报告,3分 先采用绿色环保包装,2分 |
|
5 |
全程溯源体系 |
具备溯源系统,实现生产全流程溯源,“一品一码”,5分 |
表A 1.1 卡利姆茶叶认证综合评分表(续)
类别 |
分值 |
认证内容 |
备注说明 |
科技创新 |
10 |
获得质量相关认证证书 |
认证1项加3分 |
10 |
参与标准制定 |
团体标准1项加5分,行业标准1项8分,国家标准1项加10分 |
|
5 |
开展课题研究 |
根据课题情况,打0-5分 |
|
5 |
具备相关知识产权 |
实用新型专利和软件著作权1项加2分;发明专利1项5分 |
|
5 |
具备质量保险 |
根据保险公司情况,0-5分 |
|
合计 |
100 |
附录B
(资料性附录)
卡利姆茶叶感官评价规则
1 审评条件
1.1 审评环境
茶叶感官审评环境应空气清新、无异味、整洁、明亮, 温度宜保持在15 ℃~27 ℃, 相对湿度不高于70%,评茶期间噪声应不超过50 dB。其它条件应符合GB/T 18797的规定。审评设备按照GB/T 23776。
1.2 审评用水
审评用水的pH5.5~7,硬度<10,其它卫生要求应符合GB 5749的要求。茶叶审评用水应一致。
1.4 审评人员
1.4.1 身体健康,感觉器官(视觉、嗅觉、味觉、触觉)正常,无明显体味。
1.4.2 应具备良好的职业道德,长期从事茶叶审评相关工作,具有丰富的审评实践经验和相应的专业理论知识。主评人员应获得相关专业高级职称或高级评茶技师(一级)职业资格,其余若干副评人员应 获得相关专业中级职称或评茶技师(二级)职业资格,助理人员应获得相关专业初级职称或初级评茶员 (五级)及以上职业资格或具有相应的茶叶审评技能操作水平。
2 审评
2.1 取样方法
2.1.1 初制茶取样方法
按照GB/T 23776的规定执行。
2.1.2 精制茶取样方法
按照GB/T 8302的规定执行。
2.2 审评内容
2.2.1.1 初制茶
按照茶叶的外形(包括形状、嫩度、色泽、整碎和净度)、汤色、香气、滋味和叶底“五项因子”进行审评。
2.2.1.2 精制茶
按照茶叶外形的形状、色泽、整碎和净度、内质、汤色、香气、滋味和叶底“八项因子”进行审评。
2.3.1 内质审评方法
2.3.3.1 汤色
审评茶汤的色泽应及时,以茶汤表面蒸汽消失、能见度清晰为宜, 目测审评茶汤的色泽、深浅、明 亮度、清浊度等,注意光线与评茶用具等的影响,可调换审评碗的位置以减少环境光线对汤色的影响。
2.3.3.2 香气
2.3.3.2.1 盖杯闻香
一手拿起杯盖,向上水平提起,杯盖内侧靠近鼻孔,倾斜杯盖与脸部平面呈45°左右,吸嗅杯盖内 侧的香气,每次嗅香不超过3 s,后随即将杯盖放回。可反复1~2次,判断香气类型、程度、纯度和持 久度。热嗅(杯温约75 ℃) 判别香气的类型和纯异,温嗅(杯温约45 ℃) 判别香气的质量高低,冷嗅 (杯温接近室温)判别香气的持久度,三者结合进行评判。
2.3.3.2.2 柱形杯闻香
一手持杯,一手持盖,开杯盖与杯口平面呈45°左右,杯盖一角不离开杯口,靠近鼻孔,嗅评杯中 香气,每次持续3 s内,后随即合上杯盖。可反复1~2次,判断香气的类型、浓度、鲜纯度与持久度。 并热嗅、温嗅、冷嗅结合进行。
2.3.3.3 滋味
审评滋味的茶汤温度以45 ℃左右为宜。用茶匙取适量(5 mL左右)茶汤于小茶杯内,吸吮小茶杯 内的茶汤,与舌头各部分的味蕾充分接触,根据5.2的审评内容审评滋味。
2.3.3.4 叶底
精制茶采用黑色叶底盘,毛茶与乌龙茶等采用白色搪瓷叶底盘,操作时应将杯中的茶叶全部倒入叶 底盘中,其中白色搪瓷叶底盘中要加入适量清水,各叶底盘中水量一致,漂看叶底。用目测、手触感等方法审评叶底。
3 品质评定
3.1 评分的形式
集体评分,集体审评由三人或5人。参加审评的人员组成一个审评小组,推荐其中一人为主评,其余人员为副评。审评过程中可由审评小组全体人员分别评出分数, 也可共同研究确定分数。如果评出的分数结果差异较大,对评分差异较大的茶样进行集体讨论或重新扦样审评,最后共同确定分数,如仍有争论,经协商,最终结果由主评决定,并加注评语。感官品质评定记录格式见附表B.1。
3.2 评分的方法
分档评分法。在对每组茶样的各项审评因子逐个进行审评的同时,针对茶样的某项审评因子无 法分出高下时,将该项审评因子划分在同一档打一样的分数。
3.3 分数的确定
3.3.1 每个评茶员所评的分数的总和除以参加评分的人数所得的分数。
3.4 结果计算
评分按外形30%、汤色10%、香气25%、滋味25%、叶底10%的审评因子评分系数计算, 其他茶类审评因子评分系数按照GB/T 23776的规定执行。
3.5 评分
茶叶感官品质评定记录表如表B1。
表B 1 茶叶感官品质评定记录表
序号 |
外形(分) |
汤色(分) |
香气(分) |
滋味(分) |
叶底(分) |
总分 |
评语 |
1 |
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
评审专家: 日期: |
附录C
(资料性附录)
欧盟茶叶农药残留限量要求
表C 1.1 欧盟茶叶农药残留限量要求
农药英文名 |
限量(mg/kg) |
1,1-dichloro-2,2-bis(4-ethylphenyl)ethane (F) |
0.1* |
1,2-dibromoethane (ethylene dibromide) (F) |
0.02* |
1,2-dichloroethane (ethylene dichloride) (F) |
0.02* |
1,3-Dichloropropene |
0.05* |
1,4-dimethylnaphthalene (R),(F) |
0.05 |
1-Naphthylacetamide and 1-naphthylacetic acid (sum of 1-naphthylacetamide and 1-naphthylacetic acid and its salts, expressed as 1-naphythlacetic acid) |
0.1* |
1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (PAM) |
|
1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide (PAM) |
|
1-methylcyclopropene |
0.05* |
2,4,5-T (sum of 2,4,5-T, its salts and esters, expressed as 2,4,5-T) (F) |
0.05* |
2,4-D (sum of 2,4-D, its salts, its esters and its conjugates, expressed as 2,4-D) |
0.1* |
2,4-DB (sum of 2,4-DB, its salts, its esters and its conjugates, expressed as 2,4-DB) (R) |
0.05* |
2,5-dichlorobenzoic acid methylester (sum of 2,5-dichlorobenzoic acid and its ester expressed as 2,5-dichlorobenzoic acid methylester) |
0.01* |
2-amino-4-methoxy-6-(trifluormethyl)-1,3,5-triazine (AMTT), resulting from the use of tritosulfuron (F) |
0.01* |
2-naphthyloxyacetic acid |
0.05* |
2-phenylphenol (sum of 2-phenylphenol and its conjugates, expressed as 2-phenylphenol) (R),(F) |
0.05* |
3-decen-2-one |
0.1* |
6-Benzyladenine |
0.05* |
8-hydroxyquinoline (sum of 8-hydroxyquinoline and its salts, expressed as 8-hydroxyquinoline) |
0.05* |
Abamectin (sum of avermectin B1a, avermectin B1b and delta-8,9 isomer of avermectin B1a, expressed as avermectin B1a) (R),(F) |
0.05* |
Acephate |
0.05* |
Acequinocyl (F) |
0.05* |
Acetamiprid (R) |
0.05* |
Acetochlor |
0.05* |
Acibenzolar-S-methyl (sum of acibenzolar-S-methyl and acibenzolar acid (free and conjugated), expressed as acibenzolar-S-methyl) |
0.05* |
Aclonifen |
0.05* |
Acrinathrin (F) |
0.05* |
Alachlor |
0.05* |
Aldicarb (sum of aldicarb, its sulfoxide and its sulfone, expressed as aldicarb) |
0.05* |
Aldrin and Dieldrin (Aldrin and dieldrin combined expressed as dieldrin) (F) |
0.02* |
Ametoctradin (R),(F) |
0.05* |
Amidosulfuron (R),(A) |
0.05* |
Aminopyralid (sum of aminopyralid, its salts and its conjugates, expressed as aminopyralid) (R) |
0.05* |
Amisulbrom |
0.05* |
Amitraz (amitraz including the metabolites containing the 2,4 -dimethylaniline moiety expressed as amitraz) |
0.1* |
Amitrole |
0.05* |
Anilazine |
0.05* |
Anthraquinone (F) |
0.02* |
Aramite (F) |
0.1* |
Asulam |
0.1* |
Atrazine (F) |
0.1* |
Azadirachtin |
0.01* |
Azimsulfuron |
0.05* |
Azinphos-ethyl (F) |
0.05* |
Azinphos-methyl (F) |
0.05* |
Azocyclotin and Cyhexatin (sum of azocyclotin and cyhexatin expressed as cyhexatin) |
0.05* |
Azoxystrobin |
0.05* |
Barban (F) |
0.05* |
Beflubutamid |
0.05* |
Benalaxyl including other mixtures of constituent isomers including benalaxyl-M (sum of isomers) |
0.05* |
Benfluralin (F) |
0.1* |
Bensulfuron-methyl |
0.05* |
Bentazone (Sum of bentazone, its salts and 6-hydroxy (free and conjugated) and 8-hydroxy bentazone (free and conjugated), expressed as bentazone) (R) |
0.1* |
Benthiavalicarb (Benthiavalicarb-isopropyl(KIF-230 R-L) and its enantiomer (KIF-230 S-D) and its diastereomers(KIF-230 S-L and KIF-230 R-D), expressed as benthiavalicarb-isopropyl) (A) |
0.05* |
Benzalkonium chloride (mixture of alkylbenzyldimethylammonium chlorides with alkyl chain lengths of C8, C10, C12, C14, C16 and C18) |
0.1 |
Benzovindiflupyr Bicyclopyrone (sum of bicyclopyrone and its structurally related metabolites determined as the sum of the common moieties 2-(2- methoxyethoxymethyl)-6-(trifluoromethyl) pyridine-3-carboxylic acid (SYN503780) and (2-(2-hydroxyethoxymethyl)-6- (trifluoromethyl)pyridine-3-carboxylic acid (CSCD686480), expressed as bicyclopyrone) |
0.05* |
Bifenazate (sum of bifenazate plus bifenazate-diazene expressed as bifenazate) (F) |
0.1* |
Bifenox (F) |
0.05* |
Bifenthrin (sum of isomers) (F) |
30.0 |
Biphenyl |
0.05* |
Bispyribac (sum of bispyribac, its salts and its esters, expressed as bispyribac) |
0.05* |
Bitertanol (sum of isomers) (F) |
0.05* |
Bixafen (R),(F) |
0.05* |
Bone oil |
0.01* |
Boscalid (R),(F) |
40.0 |
Bromadiolone |
0.01* |
Bromide ion |
70.0 |
Bromophos-ethyl (F) |
0.05* |
Bromopropylate (F) |
0.05* |
Bromoxynil and its salts, expressed as bromoxynil |
0.05* |
Bromuconazole (sum of diasteroisomers) (F) |
0.05* |
Bupirimate (R),(F),(A) |
0.05* |
Buprofezin (F) |
0.05* |
Butralin |
0.05* |
Butylate |
0.05* |
Cadusafos |
0.01* |
Camphechlor (Toxaphene) (R),(F) |
0.05* |
Captafol (F) |
0.1* |
Captan (Sum of captan and THPI, expressed as captan) (R) |
0.1* |
Carbaryl (F) |
0.05* |
Carbendazim and benomyl (sum of benomyl and carbendazim expressed as carbendazim) (R) |
0.1* |
Carbetamide (sum of carbetamide and its S isomer) |
0.05* |
Carbofuran (sum of carbofuran (including any carbofuran generated from carbosulfan, benfuracarb or furathiocarb) and 3-OH carbofuran expressed as carbofuran) (R) |
0.05* |
Carbon monoxide |
0.01* |
Carbon tetrachloride |
|
Carboxin (carboxin plus its metabolites carboxin sulfoxide and oxycarboxin (carboxin sulfone), expressed as carboxin) |
0.1* |
Carfentrazone-ethyl (sum of carfentrazone-ethyl and carfentrazone, expressed as carfentrazone-ethyl) (R) |
0.1* |
Cartap |
0.1* |
Chlorantraniliprole (F) |
0.05* |
Chlorate (A) |
0.05 |
Chlorbenside (F) |
0.1* |
Chlorbufam (F) |
0.05* |
Chlordane (sum of cis- and trans-chlordane) (R),(F) |
0.02* |
Chlordecone (F) |
0.02 |
Chlorfenapyr |
50.0 |
Chlorfenson (F) |
0.1* |
Chlorfenvinphos (F) |
0.05* |
Chloridazon (sum of chloridazon and chloridazon-desphenyl, expressed as chloridazon) (R) |
0.1* |
Chlormequat (sum of chlormequat and its salts, expressed as chlormequat-chloride) |
0.05* |
Chlorobenzilate (F) |
0.1* |
Chloropicrin |
0.025* |
Chlorothalonil (R) |
0.05* |
Chlorotoluron |
0.05* |
Chloroxuron (F) |
0.05* |
Chlorpropham (R),(F) |
0.05* |
Chlorpyrifos (F) |
0.01* |
Chlorpyrifos-methyl (R),(F) |
0.01* |
Chlorsulfuron |
0.05* |
Chlorthal-dimethyl |
0.05* |
Chlorthiamid |
0.05* |
Chlozolinate (F) |
0.05* |
Chromafenozide |
0.05* |
Cinidon-ethyl (sum of cinidon ethyl and its E-isomer) |
0.1* |
Clethodim (sum of Sethoxydim and Clethodim including degradation products calculated as Sethoxydim) |
0.1 |
Clodinafop and its S-isomers and their salts, expressed as clodinafop (F) |
0.1* |
Clofentezine (R) |
0.05* |
Clomazone |
0.05* |
Clopyralid |
0.5 |
Clothianidin |
0.7 |
Copper compounds (Copper) |
40.0 |
Coumaphos |
|
Cyanamide including salts expressed as cyanamide |
0.01* |
Cyantraniliprole |
0.05* |
Cyazofamid |
0.05* |
Cyclanilide (F) |
0.1* |
Cyclaniliprole |
0.05* |
Cycloxydim including degradation and reaction products which can be determined as 3-(3-thianyl)glutaric acid S-dioxide (BH 517-TGSO2) and/or 3-hydroxy-3-(3-thianyl)glutaric acid S-dioxide (BH 517-5-OH-TGSO2) or derivatives thereof, calculated in total as cycloxydim |
0.1* |
Cyflufenamid (sum of cyflufenamid (Z-isomer) and its E-isomer, expressed as cyflufenamid) (R),(A) |
0.05* |
Cyflumetofen (sum of isomers) |
0.05* |
Cyfluthrin (cyfluthrin including other mixtures of constituent isomers (sum of isomers)) (F) |
0.05* |
Cyhalofop-butyl |
0.1* |
Cymoxanil |
0.1* |
Cypermethrin (cypermethrin including other mixtures of constituent isomers (sum of isomers)) (F) |
0.5 |
Cyproconazole (F) |
0.05* |
Cyprodinil (R),(F) |
0.1* |
Cyromazine |
0.1* |
DDT (sum of p,p´-DDT, o,p´-DDT, p-p´-DDE and p,p´-TDE (DDD) expressed as DDT) (F) |
0.2* |
DNOC |
0.05* |
Dalapon |
0.1 |
Daminozide (sum of daminozide and 1,1-dimethyl-hydrazine (UDHM), expressed as daminozide) |
0.1* |
Deltamethrin (cis-deltamethrin) (F) |
5.0 |
Denatonium benzoate (sum of denatonium and its salts, expressed as denatonium benzoate) |
0.05* |
Desmedipham |
0.05* |
Di-allate (sum of isomers) (F) |
0.05* |
Diazinon (F) |
0.05* |
Dicamba |
0.05* |
Dichlobenil |
0.05* |
Dichlorprop (Sum of dichlorprop (including dichlorprop-P), its salts, esters and conjugates, expressed as dichlorprop) (R) |
0.1* |
Dichlorvos |
0.02* |
Dicloran |
0.05* |
Dicofol (sum of p, p´ and o,p´ isomers) (F) |
20.0 |
Didecyldimethylammonium chloride (mixture of alkyl-quaternary ammonium salts with alkyl chain lengths of C8, C10 and C12) |
0.1 |
Diethofencarb |
0.05* |
Difenoconazole |
0.05* |
Diflubenzuron (R),(F) |
0.05* |
Diflufenican (F) |
0.05* |
Difluoroacetic acid (DFA) |
0.1* |
Dimethachlor |
0.05* |
Dimethenamid including other mixtures of constituent isomers including dimethenamid-P (sum of isomers) |
0.05* |
Dimethipin |
0.1* |
Dimethoate |
0.05* |
Dimethomorph (sum of isomers) |
0.05* |
Dimoxystrobin (R),(A) |
0.05* |
Diniconazole (sum of isomers) |
0.05* |
Dinocap (sum of dinocap isomers and their corresponding phenols expressed as dinocap) (Where only meptyldinocap or its corresponding phenol are detected but none of the other components constituting dinocap (including their corresponding phenols), the MRLs and residue definition of meptyldinocap are to be applied.) (F) |
0.1* |
Dinoseb (sum of dinoseb, its salts, dinoseb-acetate and binapacryl, expressed as dinoseb) |
0.1* |
Dinotefuran |
|
Dinoterb (sum of dinoterb, its salts and esters, expressed as dinoterb) |
0.05* |
Dioxathion (sum of isomers) (F) |
0.05* |
Diphenylamine |
0.05* |
Diquat |
0.05* |
Disulfoton (sum of disulfoton, disulfoton sulfoxide and disulfoton sulfone expressed as disulfoton) (F) |
0.05* |
Dithianon |
0.01* |
Dithiocarbamates (dithiocarbamates expressed as CS2, including maneb, mancozeb, metiram, propineb, thiram and ziram) |
0.1* |
Diuron |
0.05* |
Dodemorph |
0.01* |
Dodine |
0.05* |
EPTC (ethyl dipropylthiocarbamate) |
0.05* |
Emamectin B1a and its salts, expressed as emamectin B1a (free base) (R),(F) |
0.01* |
Endosulfan (sum of alpha- and beta-isomers and endosulfan-sulphate expressed as endosulfan) (F) |
30.0 |
Endrin (F) |
0.01* |
Epoxiconazole (F) |
0.05* |
Ethalfluralin |
0.01* |
Ethametsulfuron-methyl |
0.02* |
Ethephon |
0.1* |
Ethion |
3.0 |
Ethirimol (R),(F),(A) |
0.05* |
Ethofumesate (Sum of ethofumesate, 2-keto–ethofumesate, open-ring-2-keto-ethofumesate and its conjugate, expressed as ethofumesate) |
0.1* |
Ethoprophos |
0.02* |
Ethoxyquin (F) |
0.1* |
Ethoxysulfuron |
0.05* |
Ethylene oxide (sum of ethylene oxide and 2-chloro-ethanol expressed as ethylene oxide) (F) |
0.1* |
Etofenprox (F) |
0.05* |
Etoxazole |
15.0 |
Etridiazole |
0.05* |
Famoxadone (F) |
0.05* |
Fenamidone |
0.05* |
Fenamiphos (sum of fenamiphos and its sulphoxide and sulphone expressed as fenamiphos) |
0.05* |
Fenarimol |
0.05* |
Fenazaquin (F) |
9.0 |
Fenbuconazole (sum of constituent enantiomers) |
0.05* |
Fenbutatin oxide (F) |
0.05* |
Fenchlorphos (sum of fenchlorphos and fenchlorphos oxon expressed as fenchlorphos) |
0.1* |
Fenhexamid (F) |
0.05* |
Fenitrothion |
0.05* |
Fenoxaprop-P |
0.1 |
Fenoxycarb |
0.05* |
Fenpicoxamid (R),(F) |
0.05* |
Fenpropathrin |
2.0 |
Fenpropidin (sum of fenpropidin and its salts, expressed as fenpropidin) (R),(A) |
0.05* |
Fenpropimorph (sum of isomers) (R),(F) |
0.05* |
Fenpyrazamine (F) |
0.05* |
Fenpyroximate (R),(F),(A) |
8.0 |
Fenthion (fenthion and its oxigen analogue, their sulfoxides and sulfone expressed as parent) (F) |
0.05* |
Fentin (fentin including its salts, expressed as triphenyltin cation) (F) |
0.1* |
Fenvalerate (any ratio of constituent isomers (RR, SS, RS & SR) including esfenvalerate) (R),(F) |
0.1* |
Fipronil (sum fipronil + sulfone metabolite (MB46136) expressed as fipronil) (F) |
0.005* |
Flazasulfuron |
0.05* |
Flonicamid (sum of flonicamid, TFNA and TFNG expressed as flonicamid) (R) |
0.1* |
Florasulam |
0.05* |
Florpyrauxifen-benzyl |
0.05* |
Fluazifop-P (sum of all the constituent isomers of fluazifop, its esters and its conjugates, expressed as fluazifop) |
0.05* |
Fluazinam (F) |
0.1* |
Flubendiamide (F) |
50.0 |
Flucycloxuron (F) |
0.05* |
Flucythrinate (flucythrinate including other mixtures of constituent isomers (sum of isomers)) (F) |
0.05* |
Fludioxonil (R),(F) |
0.05* |
Flufenacet (sum of all compounds containing the N fluorophenyl-N-isopropyl moiety expressed as flufenacet) |
0.05* |
Flufenoxuron (F) |
15.0 |
Flufenzin |
0.1* |
Flumequine |
|
Flumetralin (F) |
0.05* |
Flumioxazine |
0.1* |
Fluometuron |
0.05* |
Fluopicolide |
0.05* |
Fluopyram (R) |
0.05* |
Fluoride ion |
400.0 |
Fluoride ion |
400.0 |
Fluoroglycofene |
0.02* |
Fluoxastrobin (sum of fluoxastrobin and its Z-isomer) (R) |
0.05* |
Flupyradifurone |
0.05* |
Flupyrsulfuron-methyl |
0.1* |
Fluquinconazole (F) |
0.05* |
Flurochloridone (sum of cis- and trans- isomers) (F) |
0.05* |
Fluroxypyr (sum of fluroxypyr, its salts, its esters, and its conjugates, expressed as fluroxypyr) (R),(A) |
0.05* |
Flurprimidole |
0.05* |
Flurtamone |
0.05* |
Flusilazole (R),(F) |
0.05* |
Flutianil |
0.05* |
Flutolanil (R) |
0.05* |
Flutriafol |
0.05* |
Fluvalinate (sum of isomers) resulting from the use of tau-fluvalinate (F) |
0.05* |
Fluxapyroxad (F) |
0.05* |
Folpet (sum of folpet and phtalimide, expressed as folpet) (R) |
0.1* |
Fomesafen |
0.05* |
Foramsulfuron |
0.05* |
Forchlorfenuron |
0.05* |
Formetanate: Sum of formetanate and its salts expressed as formetanate (hydrochloride) |
0.05* |
Formothion |
0.05* |
Fosetyl-Al (sum of fosetyl, phosphonic acid and their salts, expressed as fosetyl) |
5.0* |
Fosthiazate |
0.05* |
Fuberidazole |
0.05* |
Furfural |
1.0 |
Glufosinate (sum of glufosinate isomers, its salts and its metabolites 3-[hydroxy(methyl)phosphinoyl]propionic acid (MPP) and N-acetyl-glufosinate (NAG), expressed as glufosinate) |
0.1* |
Glyphosate |
2.0 |
Guazatine (guazatine acetate, sum of components) |
0.05* |
Halauxifen-methyl (sum of halauxifen-methyl and X11393729 (halauxifen), expressed as halauxifen-methyl) |
0.1* |
Halosulfuron methyl |
0.02* |
Haloxyfop (Sum of haloxyfop, its esters, salts and conjugates expressed as haloxyfop (sum of the R- and S- isomers at any ratio)) (R),(F) |
0.05* |
Heptachlor (sum of heptachlor and heptachlor epoxide expressed as heptachlor) (F) |
0.02* |
Hexachlorobenzene (F) |
0.02* |
Hexachlorocyclohexane (HCH), alpha-isomer (F) |
0.01* |
Hexachlorocyclohexane (HCH), beta-isomer (F) |
0.01* |
Hexaconazole |
0.05* |
Hexythiazox (any ratio of constituent isomers) (F) |
15.0 |
Hydrogen cyanide (cyanides expressed as hydrogen cyanide) |
|
Hymexazol |
0.1* |
Imazalil (any ratio of constituent isomers) (R) |
0.05* |
Imazamox (Sum of imazamox and its salts, expressed as imazamox) |
0.1* |
Imazapic |
0.01* |
Imazapyr |
|
Imazaquin |
0.05* |
Imazosulfuron |
0.05* |
Imidacloprid |
0.05* |
Indolylacetic acid |
0.1* |
Indolylbutyric acid |
0.1* |
Indoxacarb (sum of indoxacarb and its R enantiomer) (F) |
5.0 |
Iodosulfuron-methyl (sum of iodosulfuron-methyl and its salts, expressed as iodosulfuron-methyl) |
0.05* |
Ioxynil (sum of ioxynil and its salts, expressed as ioxynil) |
0.05* |
Ipconazole (F) |
0.05* |
Iprodione (R) |
0.05* |
Iprovalicarb |
0.05* |
Isofetamid |
0.05* |
Isoprothiolane |
0.01* |
Isoproturon |
0.05* |
Isopyrazam |
0.01* |
Isoxaben |
0.02* |
Isoxaflutole (sum of isoxaflutole and its diketonitrile-metabolite, expressed as isoxaflutole) |
0.1* |
Kresoxim-methyl (R) |
0.05* |
Lactofen |
0.05* |
Lambda-cyhalothrin (includes gamma-cyhalothrin) (sum of R,S and S,R isomers) (F) |
0.01* |
Lenacil |
0.1* |
Lindane (Gamma-isomer of hexachlorocyclohexane (HCH)) (F) |
0.01* |
Linuron |
0.05* |
Lufenuron (any ratio of constituent isomers) (F) |
0.05* |
MCPA and MCPB (MCPA, MCPB including their salts, esters and conjugates expressed as MCPA) (R),(F) |
0.1* |
Malathion (sum of malathion and malaoxon expressed as malathion) |
0.5 |
Maleic hydrazide |
0.5* |
Mandestrobin |
0.05* |
Mandipropamid (any ratio of constituent isomers) |
0.05* |
Mecarbam |
0.05* |
Mecoprop (sum of mecoprop-p and mecoprop expressed as mecoprop) |
0.1* |
Mefentrifluconazole |
0.05* |
Mepanipyrim |
0.05* |
Mepiquat (sum of mepiquat and its salts, expressed as mepiquat chloride) |
0.1* |
Mepronil |
0.05* |
Meptyldinocap (sum of 2,4 DNOPC and 2,4 DNOP expressed as meptyldinocap) |
0.05* |
Mercury compounds (sum of mercury compounds expressed as mercury) |
0.02 |
Mesosulfuron-methyl |
0.05* |
Mesotrione |
0.05* |
Metaflumizone (sum of E- and Z- isomers) |
0.1* |
Metalaxyl and metalaxyl-M (metalaxyl including other mixtures of constituent isomers including metalaxyl-M (sum of isomers)) (R) |
0.05* |
Metaldehyde |
0.1* |
Metamitron |
0.05* |
Metazachlor (Sum of metabolites 479M04, 479M08 and 479M16, expressed as metazachlor) (R) |
0.1* |
Metconazole (sum of isomers) (F) |
0.1* |
Methabenzthiazuron |
0.05* |
Methacrifos |
0.05* |
Methamidophos |
0.05* |
Methidathion |
0.1* |
Methiocarb (sum of methiocarb and methiocarb sulfoxide and sulfone, expressed as methiocarb) |
0.1* |
Methomyl |
0.05* |
Methoprene |
0.1* |
Methoxychlor (F) |
0.1* |
Methoxyfenozide (F) |
80.0 |
Methylisothiocyanate (resulting from the use of dazomet or metam) |
0.05* |
Metolachlor and S-metolachlor (metolachlor including other mixtures of constituent isomers including S-metolachlor (sum of isomers)) |
0.05* |
Metosulam |
0.05* |
Metrafenone (F) |
0.05* |
Metribuzin |
0.1* |
Metsulfuron-methyl |
0.05* |
Mevinphos (sum of E- and Z-isomers) |
0.02* |
Milbemectin (sum of milbemycin A4 and milbemycin A3, expressed as milbemectin) |
0.1* |
Molinate |
0.05* |
Monocrotophos |
0.05* |
Monolinuron |
0.05* |
Monuron |
0.05* |
Myclobutanil (sum of constituent isomers) (R) |
0.05* |
Napropamide (sum of isomers) |
0.05* |
Nicosulfuron |
0.05* |
Nicotine |
0.6 |
Nitrofen (F) |
0.02* |
Novaluron (F) |
0.01* |
Omethoate |
0.05* |
Orthosulfamuron |
0.05* |
Oryzalin (F) |
0.05* |
Oxadiargyl |
0.05* |
Oxadiazon |
0.05* |
Oxadixyl |
0.02* |
Oxamyl |
0.05* |
Oxasulfuron |
0.05* |
Oxathiapiprolin |
0.05* |
Oxycarboxin |
0.05* |
Oxydemeton-methyl (sum of oxydemeton-methyl and demeton-S-methylsulfone expressed as oxydemeton-methyl) |
0.05* |
Oxyfluorfen (F) |
0.05* |
Paclobutrazol (sum of constituent isomers) |
0.05* |
Paraffin oil (CAS 64742-54-7) |
0.01* |
Paraquat |
0.05* |
Parathion (F) |
0.1* |
Parathion-methyl (sum of Parathion-methyl and paraoxon-methyl expressed as Parathion-methyl) |
0.05* |
Penconazole (sum of constituent isomers) (F) |
0.05* |
Pencycuron (sum of pencycuron and pencycuron-PB-amine, expressed as pencycuron) (R),(F),(A) |
0.1* |
Pendimethalin (F) |
0.05* |
Penflufen (sum of isomers) (F) |
0.05* |
Penoxsulam |
0.05* |
Penthiopyrad (F) |
0.05* |
Permethrin (sum of isomers) (F) |
0.1* |
Pethoxamid |
0.05* |
Petroleum oils (CAS 92062-35-6) |
0.01* |
Phenmedipham |
0.05* |
Phenothrin (phenothrin including other mixtures of constituent isomers (sum of isomers)) (F) |
0.05* |
Phenthoate |
|
Phorate (sum of phorate, its oxygen analogue and their sulfones expressed as phorate) |
0.05* |
Phosalone |
0.05* |
Phosmet (phosmet and phosmet oxon expressed as phosmet) (R) |
0.1* |
Phosphamidon |
0.02* |
Phosphane and phosphide salts (sum of phosphane and phosphane generators (relevant phosphide salts), determined and expressed as phosphane) |
0.02 |
Phoxim (F) |
0.1 |
Picloram |
0.01* |
Picolinafen |
0.05* |
Picoxystrobin (F) |
0.05* |
Pirimicarb (R) |
0.05* |
Pirimiphos-methyl (F) |
0.05* |
Prochloraz (sum of prochloraz, BTS 44595 (M201-04) and BTS 44596 (M201-03), expressed as prochloraz) (F) |
0.15* |
Procymidone (R) |
0.05* |
Profenofos (F) |
0.05* |
Profoxydim |
0.05* |
Prohexadione (prohexadione (acid) and its salts expressed as prohexadione-calcium) |
0.05* |
Propachlor: oxalinic derivate of propachlor, expressed as propachlor |
0.1* |
Propamocarb (Sum of propamocarb and its salts, expressed as propamocarb) (R) |
0.05* |
Propanil |
0.05* |
Propargite (F) |
10.0 |
Propham |
0.05* |
Propiconazole (sum of isomers) (F) |
0.05* |
Propineb (expressed as propilendiamine) |
0.1* |
Propisochlor |
0.05* |
Propoxur |
0.01* |
Propoxycarbazone (propoxycarbazone, its salts and 2-hydroxypropoxycarbazone expressed as propoxycarbazone) (A) |
0.1* |
Propyzamide (R),(F) |
0.05* |
Proquinazid (R),(F) |
0.05* |
Prosulfocarb |
0.05* |
Prosulfuron |
0.05* |
Prothioconazole: prothioconazole-desthio (sum of isomers) (F) |
0.05* |
Pymetrozine (R) |
0.1* |
Pyraclostrobin (F) |
0.1* |
Pyraflufen-ethyl (Sum of pyraflufen-ethyl and pyraflufen, expressed as pyraflufen-ethyl) |
0.1* |
Pyrasulfotole |
0.02* |
Pyrazophos (F) |
0.05* |
Pyrethrins |
0.5 |
Pyridaben (F) |
0.05* |
Pyridalyl |
0.05* |
Pyridate (sum of pyridate, its hydrolysis product CL 9673 (6-chloro-4-hydroxy-3-phenylpyridazin) and hydrolysable conjugates of CL 9673 expressed as pyridate) |
0.05* |
Pyrimethanil (R) |
0.05* |
Pyriofenone |
0.05* |
Pyriproxyfen (F) |
15.0 |
Pyroxsulam |
0.05* |
Quinalphos (F) |
0.05* |
Quinclorac |
0.05* |
Quinmerac (sum of quinmerac and its metabolites BH 518-2 and BH 518-4 expressed as quinmerac) (R) |
0.1* |
Quinoclamine |
0.05* |
Quinoxyfen (F) |
0.05* |
Quintozene (sum of quintozene and pentachloro-aniline expressed as quintozene) (F) |
0.1* |
Quizalofop (sum of quizalofop, its salts, its esters (including propaquizafop) and its conjugates, expressed as quizalofop (any ratio of constituent isomers)) |
0.05* |
Repellants: tall oil |
0.01* |
Resmethrin (resmethrin including other mixtures of consituent isomers (sum of isomers)) (F) |
0.05* |
Rimsulfuron |
0.05* |
Rotenone |
0.02* |
Saflufenacil (sum of saflufenacil, M800H11 and M800H35, expressed as saflufenacil) (R) |
0.03* |
Sedaxane (sum of isomers) |
0.05* |
Silthiofam |
0.05* |
Simazine |
0.05* |
Sintofen |
0.05* |
Sodium 5-nitroguaiacolate, sodium o-nitrophenolate and sodium p-nitrophenolate (Sum of sodium 5-nitroguaiacolate, sodium o-nitrophenolate and sodium p-nitrophenolate, expressed as sodium 5-nitroguaiacolate) |
0.15* |
Spinetoram (sum of spinetoram-J and spinetoram-L) (F),(A) |
0.1* |
Spinosad (spinosad, sum of spinosyn A and spinosyn D) (F) |
0.1* |
Spirodiclofen (F) |
0.05* |
Spiromesifen |
50.0 |
Spirotetramat and spirotetramat-enol (sum of), expressed as spirotetramat (R) |
0.1* |
Spiroxamine (sum of isomers) (R),(A) |
0.05* |
Streptomycin |
|
Sulcotrione (R) |
0.1* |
Sulfosulfuron |
0.05* |
Sulfoxaflor (sum of isomers) |
0.05* |
Sulfuryl fluoride |
0.05* |
Sum of M4 and M6 (both free and conjugated), expressed as pinoxaden (R),(A) |
0.1* |
Sum of diclofop-methyl, diclofop acid and its salts, expressed as diclofop-methyl (sum of isomers) |
0.1* |
Sum of metobromuron and 4-bromophenylurea, expressed as metobromuron |
0.1* |
TEPP |
0.02* |
Tebuconazole (R) |
0.05* |
Tebufenozide (F) |
0.05* |
Tebufenpyrad (F) |
0.05* |
Tecnazene (F) |
0.05* |
Teflubenzuron (F) |
0.05* |
Tefluthrin (tefluthrin including other mixtures of constituent isomers (sum of isomers)) (F) |
0.05* |
Tembotrione (Sum of parent tembotrione (AE 0172747) and its metabolite M5 (4,6-dihydroxy tembotrione), expressed as tembotrione) (R) |
0.1* |
Tepraloxydim (sum of tepraloxydim and its metabolites that can be hydrolysed either to the moiety 3-(tetrahydro-pyran-4-yl)-glutaric acid or to the moiety 3-hydroxy-(tetrahydro-pyran-4-yl)-glutaric acid, expressed as tepraloxydim) |
0.1* |
Terbufos |
0.01* |
Terbuthylazine (R),(F) |
0.05* |
Tetraconazole (F) |
0.02* |
Tetradifon |
0.05* |
Thiabendazole (R) |
0.05* |
Thiacloprid |
10.0 |
Thiamethoxam |
20.0 |
Thiencarbazone-methyl |
0.05* |
Thifensulfuron-methyl |
0.05* |
Thiobencarb (4-chlorobenzyl methyl sulfone) (A) |
0.05* |
Thiodicarb |
0.05* |
Thiophanate-methyl (R) |
0.1* |
Thiram (expressed as thiram) |
0.05* |
Tolclofos-methyl (F) |
0.05* |
Tolylfluanid (Sum of tolylfluanid and dimethylaminosulfotoluidide expressed as tolylfluanid) (R),(F) |
0.1* |
Topramezone (BAS 670H) |
0.02* |
Tralkoxydim (sum of the constituent isomers of tralkoxydim) |
0.05* |
Tri-allate |
0.1* |
Triadimefon (F) |
0.05* |
Triadimenol (any ratio of constituent isomers) |
0.05* |
Triasulfuron |
0.05* |
Triazophos (F) |
0.02* |
Triazoxide |
0.005* |
Tribenuron-methyl |
0.05* |
Trichlorfon |
0.05* |
Triclopyr |
0.05* |
Tricyclazole |
0.05* |
Tridemorph (F) |
0.05* |
Trifloxystrobin (R),(F) |
0.05* |
Triflumezopyrim |
|
Triflumizole: Triflumizole and metabolite FM-6-1(N-(4-chloro-2-trifluoromethylphenyl)-n-propoxyacetamidine), expressed as Triflumizole (R),(F) |
0.1* |
Triflumuron (F) |
0.05* |
Trifluralin |
0.05* |
Triflusulfuron (6-(2,2,2-trifluoroethoxy)-1,3,5-triazine-2,4-diamine (IN-M7222)) (A) |
0.05* |
Triforine |
0.05* |
Trimethyl-sulfonium cation, resulting from the use of glyphosate (F) |
0.05* |
Trinexapac (sum of trinexapac (acid) and its salts, expressed as trinexapac) |
0.05* |
Triticonazole |
0.02* |
Tritosulfuron |
0.05* |
Valifenalate (R),(A) |
0.05* |
Vinclozolin |
0.05* |
Warfarin |
0.01* |
Ziram |
0.2* |
Zoxamide |
0.05* |
参考文献
[1] ISO 7516:1984 固态速溶茶 取样
[2] ISO 9884-1:1994 茶叶规范袋 第 1 部分:托盘和集装箱运输茶叶用的标准袋
[3] ISO 9884-2:1999 茶叶规范袋 第 2 部分:托盘和集装箱运输茶叶用袋的性能规范
[4] ISO 11286:2004 茶 按颗粒大小分级分等
[5] ISO 11287:2011 绿茶 定义与基本要求
[6] ISO/TR 12591:2013 白茶 定义
[7] 欧盟食品安全标准